Israeli study: Pfizer vaccine is 94 percent effective

In a new Israeli study with 1.2 million test subjects, the vaccine from Pfizer and BioNTech shows good results.

A study of more than half a million fully vaccinated Israelis indicates that the corona vaccine from Pfizer and BioNTech provides 94 percent protection against covid-19.

It informs Israel’s largest health provider on Sunday.

The health provider, Clalit, further states that its researchers have tested 600,000 people who have received two doses of the US-German vaccine as well as 600,000 people who have not been vaccinated.

“There was a 94 percent reduction in the number of cases of symptomatic infection and a 92 percent decrease in the number of cases of serious illness compared to 600,000 similar test subjects who were not vaccinated,” Clalit said in a statement.

The Israeli healthcare provider does not elaborate on what lies behind “similar” test subjects.

– Vaccine efficacy is maintained in all age groups, including people over the age of 70, Clalit adds.

As a result of Israel’s extensive vaccination program, 3.8 million people in the country have already received the first dose of vaccine, while 2.4 million people have also received the second dose.

/ ritzau / AFP

Source: – Nyheder – Alle artikler by

*The article has been translated based on the content of – Nyheder – Alle artikler by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!